skip to main
|
skip to sidebar
SeguraBlawg's Autoimmunity-Inflammation Blawg
Monday, April 12, 2010
BioMed Central | Full text | Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: Effect on eosinophil density and activation in relation to pharmacokinetics
BioMed Central Full text Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: Effect on eosinophil density and activation in relation to pharmacokinetics
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Followers
Blog Archive
►
2013
(4)
►
April
(4)
►
2011
(1)
►
May
(1)
▼
2010
(13)
►
September
(1)
►
June
(5)
▼
April
(6)
Leukotriene Receptor Antagonists: Leukotriene Rece...
The Role of Leukotrienes in Inflammation — Ann Int...
NEJM -- Montelukast, a Leukotriene-Receptor Antago...
BioMed Central | Full text | Montelukast in the tr...
Age-Induced Reprogramming of Mast Cell Degranulati...
Mast Cells: Masterminds of Allergic Disease
►
February
(1)
►
2009
(20)
►
June
(3)
►
May
(3)
►
March
(2)
►
February
(4)
►
January
(8)
►
2008
(9)
►
December
(9)
About Me
Jacob N. Segura
View my complete profile
No comments:
Post a Comment